 VANCOUVER, Jan. 04, 2021 GLOBE NEWSWIRE -- January 4, 2021 - BetterLife Pharma Inc. BetterLife or the Company CSE: BETR OTCQB: BETRF FRA: NPAU, an emerging biotech company, is pleased to announce it has applied for patent protection of new 2-Bromo-LSD TD-0148A formulations and their use in the treatment of depression and mood disorders. 